Rationale: Spondyloenchondrodysplasia (SPENCD) is an autosomal recessive skeletal dysplasia by biallelic mutations in ACP5 gene encoding tartrate-resistant acid phosphatase (TRAP). The extra-osseous phenotype of SPENCD is pleiotropic and involves neurological impairment and immune dysfunction. Dentofacial abnormalities and orofacial symptoms in SPENCD patients have been little discussed in the literature.
Introduction
Spondyloenchondrodysplasia (SPENCD) is a rare autosomal recessive skeletal dysplasia featured by the presence of endochondromatous nonossifying metaphyseal and spondylar lesions. [1, 2] Endochondromatous lesions predominantly develop within the pelvis and long bones but these could also occur in other areas of endochondral growth. [3] Dorsally accentuated platyspondyly with disturbances in ossification and significantly short stature are the main clinical characteristics of SPENCD. [4] The extra-osseous phenotype of SPENCD is pleiotropic and involves neurological impairments such as spasticity, intracranial calcification, and mental retardation and immune dysfunctions including Sjogren syndrome, renal failure, vasculitis, and systemic lupus erythematosus (SLE) like pathologies. [4] [5] [6] [7] Owing to advances of genetic technology, genetic etiology of SPENCD was revealed. SPENCD is caused by biallelic mutations in ACP5 gene, which encodes tartrate-resistant acid phosphatase (TRAP). [8] TRAP plays a role in the dephosphorylation of osteopontin, which is known to affect osteoclast activity and type I interferon production. [9] The loss of TRAP activity in SPENCD patients results in increased serum osteopontin levels and abnormal osteoclast activity, leading to impaired cartilage resorption and bone dysplasia. [8] Elevated type I interferon levels due to increased osteopontin levels alter immune regulation, leading to the development of SLE like phenotype. [8, 9] Several studies have reported the skeletal, immunological, and neurological aspects of SPENCD. [1, [3] [4] [5] [6] [7] 10] However, the craniofacial manifestations of SPENCD in terms of the pathophysiology of this rare disorder are poorly documented in the literature. Herein we present clinical and radiological data regarding 2 siblings with SPENCD who were born to non-consanguineous parents. We aimed to present the maxillofacial abnormalities and orofacial symptoms associated with the pathophysiology of SPENCD and to share the diverse aspects of this pleiotropic entity.
Case presentation
The cases in this report were from 2 patients of the Temporomandibular joint (TMJ)· Orofacial Pain Clinic, Ajou University Dental Hospital, between May 2017and May 2018. The probands were 13-year-old boy and 16-year old his elder sister who were born from their unaffected nonconsanguineous parents (Fig. 1) . The ethical approval of research protocol was approved by the Institutional Review Board of the University Hospital (#AJIRB-MED-EXP-17-457). The patients and their parents agreed an approval for the publication of the cases under anonymized conditions.
Case 1
The 13-year-old boy presented malocclusion, delayed teeth eruption, and midface hypoplasia. He complained of bilateral preauricular pain, headache and myalgia in the masticatory and cervical muscles. All symptoms had begun approximately 4 years prior. He was 125.4 cm tall (À 6 SD), weighed 43 kg, and showed mental retardation.
The boy had presented with short stature, choreic movement, severe headache, hypertension, hematuria, and multiple arthralgia in the elbows, knees, wrists, fingers, ankles, and lumbar spine when he was 6 years old. Elevated levels of C-reactive protein, decreased complement levels (C3 and C4 proteins), and positive reactions to autoimmune antibodies including antinuclear antibody and anti-dsDNA had been detected. Following kidney biopsy, the condition was diagnosed as class IV lupus nephritis (Table 1) . He was clinically diagnosed as SPENCD with systemic lupus erythematous (SLE) based on radiographic and clinical findings, 7 years of age. Piroxicam, prednisolone, azathioprine, gabapentin, and topiramate had been prescribed to control arthralgic pain and headache. Furthermore, mycophenolate mofetil, atenolol, and enalapril had been commended to control hypertension and renal failure caused by lupus nephritis.
When the boy presented in our clinic, he complained of severe pain and exhibited a limited range of mouth opening. He experienced pain on palpation in several masticatory and neck muscles, bilaterally. He showed severe growth disturbances, skeletal dysplasia, immune depressions, and dentofacial anomalies. Hand and wrist radiograph series revealed growth disturbance and endochondromatous nonossifying metaphyseal and spondylar lesions. Delayed carpal ossification, decreased radial height and radial inclination, irregular border of distal radial metaphysis with enchondroma, distal ulnar metaphyseal enchondroma, and ulnar negative variance, representing altered length proportion between ulna and radius were detected (Fig. 2) . He exhibited slower eruption of permanent teeth, with delay of approximately 3 years, compared to his chronological age (Fig. 3) . Lateral cephlometric radiograph and facial computed tomographic (CT) images showed abnormal morphology of cervical vertebra and cranio-mandibular development. Cervical platyspondyly, skeletal retrognathic (ANB = 7.25°) relationships with anterior openbite, obtuse cranial base angle (N-S-Ba = 147.9°, +3.4 SD), and short cranial base (N-S = 63 cm, À4.3 SD) were detected (Fig. 4) . Axial CT images revealed delayed spheno-occipital synchondrosis, overdeveloped and anteriorly displaced sphenoidal sinuses, and compressed ethmoidal sinuses (Fig. 5 ). As part of the diagnostic work up, genetic testing was conducted. Whole exome sequencing performed and Conservative management was instituted, including habit control and exercise, but a stabilization splint could not be applied due to delayed eruption. A routine follow-up was conducted for 12 months, and no further teeth eruption or skeletal growth was observed during this period. Levels of the masticatory and cervical muscle pain and TMJ arthralgia had changed in accordance with his systemic condition. Relapse followed by worsening of facial symptoms was noted when he stopped steroid therapy owing to hypertension. Orthodontic treatment was carefully considered but his parents declined it owing to the medication, masticatory muscle pain, and arthralgic pain in the TMJs. His parents are aware of prognosis of his disease and have consented to continue with the conservative treatment in order to control symptoms originating from the orofacial areas.
Case 2
The 16-year-old girl who was elder sister of case 1 complained of bilateral preauricular pain and headache which had begun approximately 3 years previously. She was 144.2 cm tall (À 3 SD) and weighed 40 kg. Similar to her brother, she had shown involuntary hand movements, pain in the lumbar and thoracic spine, and severe headache at the age of 10 years (Table 1) . Elevated levels of C-reactive protein and decreased levels of C3 and C4 proteins had been detected along with positive reactions to autoimmune antibodies (Table 1) . She was clinically diagnosed with SPENCD with SLE at the age of 10 years. She had complained of intermittent severe thoracic and lumbar pain and was prescribed with corticosteroids and infliximab.
When she presented in our clinic, she complained of pain on palpation in preauricular area, bilaterally. Panoramic radiograph showed approximately 3 to 4 years delay in dental maturation. Hand and wrist radiograph series revealed diffuse sclerotic changes in the radiocarpal joint. Lateral cephalometric radiograph revealed cervical platyspondyly and CT images revealed no significant skeletal problems. A genetic analysis test was performed and the heterozygous for a missense mutations at ACP5, c.449T>A (p.Val150Glu, V150E) and c.136C>T (p. Arg46Trp, R46W) as same as her younger brother.
Conservative management was instituted, including habit control, exercise, and a stabilization splint. Her TMJ arthralgia was relieved after 1 month, but no further dental or skeletal growth was observed during 12 month follow-up period. In addition, no relapse in the thoracic and lumbar pain was noted during the treatment period.
Discussion
SPENCD, a clinically heterogeneous disease which encompasses diverse conditions, including skeletal dysplasia, immune dysregulation, and neurological impairments is caused by biallelic ACP5 mutation. [1, 3, 4, 8, 11] Abnormal osteoclast activity and increased serum levels of type I interferon in SPENCD patients may cause aberrations in the endochondral ossification process and autoimmune phenotypes. [8, 11] Compromised endochondral ossification and dysregulated immunological functions may induce orofacial pain and cause abnormal dentofacial growth, unique facial profiles, and malocclusion. However, clear associations among the pathophysiology of SPENCD, orofacial pain, and dentofacial abnormalities have not been documented so far. Short stature, cervical platyspondyly, growth disturbance with multiple deformities of the wrist, and autoimmunity are regarded as main clinical features of SPENCD, [1, 3, 4] and these were observed in both probands in the present study. Interestingly delayed sphenooccipital synchondrosis, obtuse cranial base angle, overdeveloped and anteriorly displaced sphenoidal sinuses, and compressed ethmoidal sinuses were observed in the boy. Unlike other craniofacial bones which are mostly formed through intramembranous ossification, spheno-occipital synchondrosis is a major cartilaginous growth site in the cranium and acts as principal growth center of the basicranium. Endochondral bone growth in sphenooccipital synchondrosis is associated with the primary displacement of the sphenoid and occipital bones. [12] The interior of the sphenoid bone becomes hollow to form a sizable sphenoid sinus after displacement. [12] Delayed synchondrosis due to the inhibition of endochondral ossification may lead to development of a short and flat posterior cranial base. Obtuse cranial base angle creates a downward and forward positions of the nasomaxillary complex, which may rotate the mandible downward and backward to form a retrognathic skeletal relationship and overdeveloped and anteriorly displaced sphenoidal sinuses. [12] Displaced sphenoidal sinuses would inhibit ethmoidal sinus development. Previous studies already reported dysmorphic facial profiles in patients with SPENCD, such as prominent premaxilla and retrognathia. [3] Altered cranial base development may cause midface hypoplasia and prominent premaxilla. Similar facial patterns have been observed in patients with achondroplasia and metatrophic dysplasia which is also characterized by alteration in endochondral ossification. [13, 14] Delayed dental development was observed in both patients. SPENCD is caused by biallelic mutations in ACP5 gene, which encodes TRAP. TRAP is known to play a role in osteoclast activity in the alveolar bone. [15] During dental development, TRAP-positive osteoclasts were found around tooth-bone interface and remove bone as the tooth germ expanded. [15] Alteration in TRAP activity mediated by ACP5 mutations may influence on tooth development and tooth eruption which may prevent normal dental maturation and occlusion.
Both patients have experienced bilateral TMJ arthralgia and multiple joint pains. Although the pediatric rheumatologist had not reached a diagnosis of juvenile idiopathic arthralgia (JIA), it might be suspected in these cases on the basis of their symptoms. Previous reports have showed co-existence of JIA and SPENCD [5] and the presence of pain and functional impairment of TMJ in patients with JIA has also been reported. [16] Therefore, preauricular pain in patients with SPENCD might considered as products of autoimmunity. In summary, here we present craniofacial manifestations of SPENCD in 2 young patients on the basis of genetic, radiographic, and clinical data. Previous reports have focused upon the immunological and neurological aspects, but sparse reports have investigated dentofacial abnormalities in patients with SPENCD. Since not enough cases of SPENCD have been reported, the treatment protocol of growth disturbances or dentofacial anomalies have not been established. The patient with greater severity of SPENCD showed more severe dentofacial anomaly. This would imply that the dentofacial manifestations might be related with the pathophysiology of SPENCD. Including steps of evaluating dental and craniofacial growth as well as orofacial pain in diagnostic work up of SPENCD is necessary. On the basis of findings of this study, we further recommend interdisciplinary approach of patient management including pediatric radiologist, rheumatologist, orthopedic surgeon, and dentist. Finally this may eventually help improve quality of life among patients with SPENCD.
